(Q40535159)

English

Safety and tolerability profile of daclizumab in patients with relapsing-remitting multiple sclerosis: An integrated analysis of clinical studies

scientific article published on 11 May 2016

Statements

Safety and tolerability profile of daclizumab in patients with relapsing-remitting multiple sclerosis: An integrated analysis of clinical studies (English)
Kimberly Umans
Peter McCroskery
11 May 2016
36-46

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit